Nippon Kayaku Co (FRA:NP7) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NP7 Nippon Kayaku Co Ltd FRA:NP7
86 GF Score
Price €10.40
GF Value €9.10
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Nippon Kayaku Co Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:NP7
86GF Score
Nippon Kayaku Co Ltd FRA:NP7
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nippon Kayaku Co (FRA:NP7) Overvalued in 2026?

Based on GuruFocus' analysis, Nippon Kayaku Co stock appears to be overvalued. The current stock price of €10.40 is trading 14.3% above its estimated GF Value™ of €9.10. GuruFocus considers Nippon Kayaku Co to be Modestly Overvalued.

Key valuation signals for FRA:NP7:

  • Dividends Received:
  • GF Value™: €9.10 vs. price of €10.40 (14.3% above fair value)
  • GF Score™: 86/100 with 7 warning signs

No single metric tells the full story. See the FRA:NP7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nippon Kayaku Co Business Description

Other Exchanges NPKYY:USA4272:Japan
Address 1-1, Marunouchi 2-chome, Chiyoda-ku, Meiji Yasuda Seimei Building 19th and 20th Floors, Tokyo, JPN, 100-0005
Nippon Kayaku Co Ltd manufactures and sells a variety of chemicals. The firm organizes itself into four segments based on product type. The functional chemicals segment, which generates more revenue than any other segment, sells epoxy resins used as flame retardants in electronics, colorants and dyes used in inkjet printers and the manufacture of textiles. The pharmaceuticals segment sells anti-cancer drugs, biological drugs, cardiovascular agents, vitamin compounds, and anti-inflammatory agents. The safety systems segment sells airbag inflators and micro gas generators for seatbelt pretensioners to the automotive industry, both of which are used to protect passengers during an accident. The agrochemicals segment sells insecticides and herbicides. The majority of revenue comes from Asia.
86GF Score

Get the complete analysis for FRA:NP7

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.40
Price
€9.10
GF Value